The sales of blood and blood forming organs medicine in Canada are forecasted to increase steadily from 2024 to 2028, showing a consistent growth with values rising from $1.47 billion in 2024 to $1.75 billion in 2028. Compared to the baseline year 2023, the projected data indicates a gradual year-on-year growth rate of approximately 4.76%. The compound annual growth rate (CAGR) is anticipated to be about 4.4% over the five-year forecast period.
Future trends to watch for:
- Advancements in biotechnology impacting product innovation and sales.
- Government policies or healthcare reforms affecting pricing or accessibility.
- Global economic factors and their influence on healthcare spending.
- Potential competition from alternative therapies or generic medicine.
